Cencora, Inc. (COR)
NYSE: COR · Real-Time Price · USD
333.41
-6.27 (-1.85%)
Nov 6, 2026, 4:00 PM EST - Market closed
Cencora Revenue
In the fiscal year ending September 30, 2026, Cencora had annual revenue of $337.40B with 5.00% growth. Cencora had revenue of $88.35B in the quarter ending September 30, 2026, with 5.52% growth. That makes Cencora the 15th largest company in the world by revenue and 10th in the United States.
Revenue (ttm)
$337.40B
Revenue Growth
+5.00%
P/S Ratio
0.19
Revenue / Employee
$6,615,633
Employees
51,000
Market Cap
63.62B
Revenue by Segment
- Total US Healthcare Solutions 298.13B 88.3%
- Total International Healthcare Solutions 30.67B 9.1%
- Other Segment 8.74B 2.6%
Fiscal year ended Sep 30, 2026 See the full Cencora breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2026 | 337.40B | 16.06B | 5.00% |
| Sep 30, 2025 | 321.33B | 27.37B | 9.31% |
| Sep 30, 2024 | 293.96B | 31.79B | 12.12% |
| Sep 30, 2023 | 262.17B | 23.59B | 9.89% |
| Sep 30, 2022 | 238.59B | 24.60B | 11.50% |
| Sep 30, 2021 | 213.99B | 24.09B | 12.69% |
| Sep 30, 2020 | 189.89B | 10.30B | 5.74% |
| Sep 30, 2019 | 179.59B | 11.65B | 6.94% |
| Sep 30, 2018 | 167.94B | 14.80B | 9.66% |
| Sep 30, 2017 | 153.14B | 6.29B | 4.29% |
| Sep 30, 2016 | 146.85B | 10.89B | 8.01% |
| Sep 30, 2015 | 135.96B | 16.39B | 13.71% |
| Sep 30, 2014 | 119.57B | 31.61B | 35.94% |
| Sep 30, 2013 | 87.96B | 9.88B | 12.65% |
| Sep 30, 2012 | 78.08B | -614.85M | -0.78% |
| Sep 30, 2011 | 78.70B | 919.20M | 1.18% |
| Sep 30, 2010 | 77.78B | 6.02B | 8.38% |
| Sep 30, 2009 | 71.76B | 1.57B | 2.24% |
| Sep 30, 2008 | 70.19B | 8.92B | 14.56% |
| Sep 30, 2007 | 61.27B | 454.37M | 0.75% |
| Sep 30, 2006 | 60.81B | 10.80B | 21.59% |
| Sep 30, 2005 | 50.01B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| McKesson | 418.79B |
| Cardinal Health | 257.75B |
| Henry Schein | 13.73B |
| Accendra Health | 2.65B |
| 111, Inc. | 1.54B |
| EDAP TMS | 79.31M |
| Cosmos Health | 73.73M |
| Akso Health Group | 13.83M |
COR News
- 1 day ago - Cencora price target raised to $360 from $345 at BofA - TheFly
- 1 day ago - Cencora price target raised to $380 from $350 at Evercore ISI - TheFly
- 1 day ago - Cencora price target raised to $405 from $375 at Baird - TheFly
- 2 days ago - Cencora Earnings Call Transcript: Q4 2026 - Transcripts
- 2 days ago - Cencora Earnings release: Q4 2026 - Filings
- 2 days ago - Cencora Slides: Q4 2026 - Filings
- 2 days ago - Cencora reports new organizational and reporting structure - TheFly
- 2 days ago - Cencora sees FY27 adjusted EPS $19.40-$19.75, consensus $19.76 - TheFly